NCT05671016View on ClinicalTrials.gov

Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy

CompletedOBSERVATIONAL

Enrollment

125

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

September 1, 2021

Study Completion Date

December 31, 2021

Conditions

Glioblastoma Multiforme, AdultRadiation ToxicityQuality of Life

Interventions

PROCEDURE

MRI scans and questionnaires

Extra baseline MRI scan performed and questionnaires (EORTC validated questionnaires involving EORTC QLQ C-30, EORTC BN20 and EORTC ELD14) to assess quality of life at baseline, 4 weeks and 8 weeks after treatment

Trial Locations (1)

BN2 5BE

Scott Harfield, Brighton

All Listed Sponsors

lead

Brighton and Sussex University Hospitals NHS Trust

OTHER

NCT05671016 - Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy | Biotech Hunter | Biotech Hunter